Cargando…
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387989/ https://www.ncbi.nlm.nih.gov/pubmed/36705279 http://dx.doi.org/10.18553/jmcp.2023.29.2.216 |
| _version_ | 1785082009033375744 |
|---|---|
| author | Nikitin, Dmitriy Makam, Anil N Suh, Kangho McKenna, Avery Carlson, Josh J Richardson, Marina Rind, David M Pearson, Steven D |
| author_facet | Nikitin, Dmitriy Makam, Anil N Suh, Kangho McKenna, Avery Carlson, Josh J Richardson, Marina Rind, David M Pearson, Steven D |
| author_sort | Nikitin, Dmitriy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10387989 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103879892023-07-31 The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council Nikitin, Dmitriy Makam, Anil N Suh, Kangho McKenna, Avery Carlson, Josh J Richardson, Marina Rind, David M Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2023-02 /pmc/articles/PMC10387989/ /pubmed/36705279 http://dx.doi.org/10.18553/jmcp.2023.29.2.216 Text en Copyright © 2023, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Nikitin, Dmitriy Makam, Anil N Suh, Kangho McKenna, Avery Carlson, Josh J Richardson, Marina Rind, David M Pearson, Steven D The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title | The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full | The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_fullStr | The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_full_unstemmed | The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_short | The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council |
| title_sort | effectiveness and value of amx0035 and oral edaravone for amyotrophic lateral sclerosis: a summary from the institute for clinical and economic review’s midwest comparative effectiveness public advisory council |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387989/ https://www.ncbi.nlm.nih.gov/pubmed/36705279 http://dx.doi.org/10.18553/jmcp.2023.29.2.216 |
| work_keys_str_mv | AT nikitindmitriy theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT makamaniln theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT suhkangho theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT mckennaavery theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT carlsonjoshj theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT richardsonmarina theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT rinddavidm theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend theeffectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT nikitindmitriy effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT makamaniln effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT suhkangho effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT mckennaavery effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT carlsonjoshj effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT richardsonmarina effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT rinddavidm effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend effectivenessandvalueofamx0035andoraledaravoneforamyotrophiclateralsclerosisasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil |